Sadly we live in a world where the truth is under attack from those with vested interests in the status quo. CBD is gaining so much traction that big pharma sees it as a major threat to their profits and is going on the offensive. They do not want CBD to be seen as safe unless it is the version of the drug they own and sell. Forbes directly benefits by getting lots of traffic to the alarming article from scared readers. Anyone who vets sources will see that “one small study, on mice, with a highly questionable methodology, published in a marginal journal, with major flaws, leads to a clickbait media panic.”
The need to study cannabis benefits and risks is important. Unfortunately, the US government (DEA) has prevented needed medical research by categorizing cannabis as Schedule 1. Fortunately, other countries have performed far more extensive research to verify the impacts of cannabis. But most importantly we need to demand sound science to truly understand how phytocannabinoids interact with our ECS. The Forbes article is based on junk science from a single Arkansas study. We need better studies, this Little Rock research is not even worthy of public consideration.
In particular, the study looks at megadosing hexane (neuro-toxin) extracted CBD isolate on 6 mice. The mice were given doses that would equate to humans consuming hundreds of grams of CBD (not 20-50 mg suggested dose) for weeks. Realistic dosages are 100s of times less as few people could ever afford that much. Second, mice respond very differently to cannabinoids than humans and Allometric scaling has not been valid in previous research. Numerous studies have demonstrated we can not extrapolate cannabis research from mice to humans using this scaling as cannabinoids are not free in the bloodstream because they bind with protein. Of course, there is the fact that many humans have used CBD for years and no pattern of liver toxicity has been observed.
So what happened? Forbes chose to cherry-pick one flawed study from a disrespected journal without meaningful peer review. The article is rife with bias and simply does not meet basic scientific standards. Clearly, if you pay enough, you can get published in journals that seem legitimate on the surface. Which means it is our responsibility to sift through the garbage science and not just accept what we see in our news feed. We need to be skeptical of these hit pieces and demand proof of alarming claims.
NEK Hemp does not extract CBD isolate with toxic Hexane. We grow organic hemp and use clean, residue-free CO2 superfluid critical extraction to create full-spectrum CBD rich products. The safety of our customers matters a great deal to us and we make every choice to ensure the highest quality possible. We will continue to monitor all sound scientific research, but the preponderance of good evidence supports our claims that CBD is safe and effective.